1,570
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Diagnosis and treatment of diabetic ketoacidosis

, MBChB, FCP(SA), MMed(Int), MSc(Clinical epidemiology)
Pages 35-39 | Published online: 15 Aug 2014

References

  • Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: A population-based study. American Journal of Epidemiology 1983; 117(5): 551–8.
  • Otieno CF, Kayima JK, Omonge EO, Oyoo GO. Diabetic ketoacidosis: Risk factors, mechanisms and management strategies in sub-Saharan Africa: A review. East African Medical Journal 2005; 82(12 Suppl): S197–203.
  • Newton CA, Rashkin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus. Clinical and biochemical differences. Arc Intern Med 2004; 164: 1925–31.
  • Rheeder P, Stolk RP, Grobbee DE. Ethnic differences in C-peptide levels and anti-GAD antibodies in South African patients with diabetic ketoacidosis. Q J Med 2001; 94: 39–43.
  • Kitabachi AE, Murphy MB, Umpierrez GE, Kreisberg RA. Hyperglycemic crisis in patients with diabetes mellitus. Position statement. Diabetes Care 2006; 29(12): 2739–48.
  • Newton CA, Rashkin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus. Clinical and biochemical differences. Arch Intern Med 2004; 164: 1925–31.
  • Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care 2002; 17: 63–7.
  • Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crisis in urban blacks. Arch Intern Med 1997; 157: 669–75.
  • American diabetes association. Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care 2003; 26(Suppl 1): S109–17.
  • American diabetes association. Hyperglycemic crises in diabetes. Diabetes Care 2004; 27(Suppl 1): S94–102.
  • Jenkins D, Close CF, Krentz AJ, Nattrass M, Wright AD. Euglycaemic diabetic ketoacidosis: Does it exist? Acta Diabetologica 1993; 30(4): 251–3.
  • Sacks DB, Burns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry 2002; 48(3): 436–72.
  • Meas T, Taboulet P, Sobngwi E, Gautier JF. Is capillary ketone determination useful in clinical practice? In which circumstances? Diabetes Metab 2005; 31: 299–303.
  • Guerci B, Tubiana-Rufi N, Bauduceau B, Bresson R, Cuperlier A, Delcroix C, et al. Advantages to using capillary blood ε-hydroxybuterate determination for the detection and treatment of diabetic ketosis. Diabetes Metab 2005; 31: 401–6.
  • Taboulet P, Hass H, Porcher R, Manamani J, Fontaine JP, Feugeas JP, et al. Urinary acetoacetate or capillary β-hydroxybuterate for the diagnosis of ketoacidosis in the emergency department setting. Eur J of Emerg Med 2004; 11: 251–8.
  • Kreshak A, Chen EH. Arterial blood gas analysis: Is its value needed for the management of diabetic ketoacidosis? Ann of Emerg Med 2005; 45(5): 550–1.
  • Carroll P. Matz R. Adult respiratory distress syndrome complicating severely uncontrolled diabetes mellitus: Report of nine cases and a review of the literature. Diabetes Care 1982; 5(6): 574–80.
  • Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997; 350(9090): 1505–10.
  • Trachtenbarg DE. Diabetic ketoacidosis. American Family Physician 2005; 71(9): 1705–14.
  • Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabetic Medicine 1993; 10(3): 282–4.
  • Mbugua PK, Otieno CF, Kayima JK, Amayo AA, McLigeyo SO. Diabetic ketoacidosis: Clinical presentation and precipitating factors at Kenyatta National Hospital, Nairobi. East African Medical Journal 2005; 82(12 Suppl): S191–6.
  • Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, et al. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. Journal of Clinical Psychiatry 2007; 68(4): 533–41.
  • Jin H, Meyer JM, Jeste DV. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases. Annals of Clinical Psychiatry 2002; 14(1): 59–64.
  • Musey VC, Lee JK, Crawford R, Klatka MA, McAdams D, Phillips LS. Diabetes in urban African-Americans. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care 1995; 18(4): 483–9.
  • Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial. Diabetic Medicine 2006; 23(3): 278–84.
  • Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N. Overview of the diagnosis and management of diabetic ketoacidosis. American Journal of the Medical Sciences 2006; 331(5): 243–51.
  • Wallace TM, Matthews DR. Recent advances in the monitoring and management of diabetic ketoacidosis. Qjm 2004; 97(12): 773–80.
  • Noyes KJ, Crofton P, Bath LE, Holmes A, Stark L, Oxley CD, et al. Hydrxybuterate near-patients testing to evaluate a new endpoint for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatric Diabetes 2007; 8(3): 150–6.
  • Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee WRW, et al. Diabetic ketoacidosis, ISPAD clinical practice consensus guiedelines 2006–2007.
  • Pediatric Diabetes 2007; 8:20–43.
  • Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care 2006; 29(5): 1150–9.
  • Agus MS, Alexander JL, Mantell PA. Continuous non-invasive end-tidal CO2 monitoring in pediatric inpatients with diabetic ketoacidosis. Pediatric Diabetes 2006; 7(4): 196–200.
  • Garcia E, Abramo TJ, Okada P, Guzman DD, Reisch JS, Wiebe RA. Capnometry for noninvasive continuous monitoring of metabolic status in pediatric diabetic ketoacidosis. Critical Care Medicine 2003; 31(10): 2539–43.
  • McBride ME, Berkenbosch JW, Tobias JD. Transcutaneous carbon dioxide monitoring during diabetic ketoacidosis in children and adolescents. Paediatric Anaesthesia 2004; 14(2): 167–71.
  • American Diabetes Association. Hospital admission guidelines for diabetes. Diabetes Care 2004; 27(Suppl 1): S103.
  • Henriksen OM, Prahl JB, Roder ME, Svendsen OL. Treatment of diabetic ketoacidosis in adults in Denmark: A national survey. Diabetes Research & Clinical Practice 2007; 77(1): 113–9.
  • Haas RM, Hoffman AR. Treatment of diabetic ketoacidosis: Should mode of insulin administration dictate use of intensive care facilities? American Journal of Medicine 2004; 117(5): 357–8.
  • Singh RK, Perros P, Frier BM. Hospital management of diabetic ketoacidosis: Are clinical guidelines implemented effectively? Diabetic Medicine 1997; 14(6): 482–6.
  • Waller SL, Delaney S, Strachan MW. Does an integrated care pathway enhance the management of diabetic ketoacidosis? Diabetic Medicine 2007; 24(4): 359–63.
  • Owen OE, Licht JH, Sapir DG. Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes 1981; 30(6): 510–8.
  • Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, et al. European Society for Paediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 2004; 113(2): e133–40.
  • Protocol for the acute management of diabetic ketoacidosis in adults. 2005. Available www.diabetesinscotland.org/diabetes/maintainpages/pdffiles/DKA_protocol.pdf/. (Accessed 20/09/2007).
  • Chiasson JL, Aris-Jilwan N, Belanger R, Bertrand S, Beauregard H, Ekoe JM, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Canadian Medical Association Journal 2003; 168(7): 859–66.
  • Rheeder P, Oosthuizen H. Treatment of hyperglycemic emergencies, 2004: The Pretoria approach. JEMDSA 2004; 9(1): 22–4.
  • Burghen GA, Etteldorf JN, Fisher JN, Kitabchi AQ. Comparison of high-dose and low-dose insulin by continuous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care 1980; 3:15–20.
  • Alberti KG. Low-dose insulin in the treatment of diabetic ketoacidosis. Arch Intern Med 1977; 137: 1367–76.
  • Edge JA, Jakes RW, Roy Y Hawkins M, Winter D, Ford-Adams ME, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006; 49(9): 2002–9.
  • Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine 2004; 117(5): 291–6.
  • Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 2004; 27(8): 1873–8.
  • Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Annals of Internal Medicine 1986; 105(6): 836–40.
  • Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. Journal of Clinical Endocrinology & Metabolism 1983; 57(1): 177–80.
  • Levy-Marchal C, Papoz L, De Beaufort C, Doutreix J, Froment V, Voirin J, et al. Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabet Med 1992; 9:279–84.
  • Ellis DA, Templin T, Naar-King S, Frey MA, Cunningham PB, Podolski CL, et al. Multisystemic therapy for adolescents with poorly controlled type I diabetes: Stability of treatment effects in a randomized controlled trial. Journal of Consulting & Clinical Psychology 2007; 75(1): 168–74.
  • Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabetic Medicine 1993; 10(3): 282–4.
  • Chapman J, Wright AD, Nattrass M, FitzGerald MG. Recurrent diabetic ketoacidosis. Diabetic Medicine 1988; 5(7): 659–61.
  • Chauhan SP, Perry KG Jr, McLaughlin BN, Roberts WE, Sullivan CA, Morrison JC. Diabetic ketoacidosis complicating pregnancy. Journal of Perinatology 1996; 16(3 Pt 1): 173–5.
  • Kilvert JA, Nicholson HO, Wright AD. Ketoacidosis in diabetic pregnancy. Diabetic Medicine 1993; 10(3): 278–81.
  • Ramin KD. Diabetic ketoacidosis in pregnancy. Obstetrics & Gynecology Clinics of North America 1999; 26(3): 481–8.
  • Hagay ZJ, Weissman A, Lurie S, Insler V. Reversal of fetal distress following intensive treatment of maternal diabetic ketoacidosis. American Journal of Perinatology 1994; 11(6): 430–2.